11 Dec 2019 | 8:12 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
585.00
5.00
(0.87 %)
11 Dec 2019 | 04:01 PM
Change company
  • Open (Rs)
    580.65
  • Prev. close (Rs.)
    580.00
  • High (Rs.)
    585.00
  • Low (Rs.)
    576.50
  • 52W H (Rs.)
    717.50
  • 52W L (Rs.)
    482.00
  • Volume
    1415
  • MCap (Rs in Cr.)
    10,640.39
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
35.31
Operating Margin (%)
37.94
Gross Profit Margin (%)
34.07
Net Profit Margin (%)
30.76
Total Debt/Equity
0.11
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

13 Nov 2019 - 21:00:00-Natco Pharma Ltd...
12 Nov 2019 - 15:10:00-The company reported standalone net profit of Rs 122...
10 Oct 2019 - 15:50:00-As of September 2019 26.90% is owned by Indian Promoters and 51.02% by Public...
01 Oct 2019 - 12:09:00-Drug firm Natco Pharma on Tuesday said it has received establishment inspection report (EIR) from th...

Announcements

06-Dec-2019
Natco Pharma - Related Party Transactions
06-Dec-2019
Natco Pharma - Related Party Transactions For The Half Year Ended September 302019
03-Dec-2019
Natco Pharma - Acquisition
03-Dec-2019
Natco Pharma - Announcement under Regulation 30 (LODR)-Updates on Acquisition
15-Nov-2019
Natco Pharma - Investor Presentation

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 25.08 -0.87
4,00,000 90.05 138.46 -0.89
4,00,000 90.05 147.61 -0.89
4,00,000 90.05 45.96 -0.88
1,60,000 35.89 73.27 -0.58

Shareholding Pattern

       
Promotors48.98%
Mutual Funds/UTI7.37%
FI/Banks1.60%
Insurance1.60%
FII21.59%
Government0.00%
Others3.95%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
12,515.00(0.19)
3280
 Sanofi India Ltd.
6,995.00(0.84)
3325
 Pfizer Ltd.
4,234.60(0.29)
3370
 Dr. Reddy`s Laboratories Ltd.
2,885.75(-0.39)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.4.555.7043.80
NIFTY(S&P CNX)-3.30874.45-55.45
BSE SENSEX67.493,141.75462.11
BSE 500-104.68998.28-237.40

Corporate Details

Key Personal
D Linga Rao
Director & President (Tech. Affairs)
P S R K Prasad
Director & Exe. VP (Corp. Engg. Services)
Rajeev Nannapaneni
Vice Chairman & CEO
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar